Apurinic Apyrimidinic Endonuclease/Redox Effector Factor 1 Immunoreactivity and Grading in Hepatocellular Carcinoma Risk of Relapse After Liver Transplantation

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1204-1208

  Avellini, C ^a   Orsaria, M ^a   Baccarani, U ^a   Adani, G L ^a   Lorenzin, D ^a   Bresadola, V ^a   Bresadola, F ^a   Beltrami, C A ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; REDOX EFFECTOR FACTOR 1;

ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CELL NUCLEUS; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CYTOPLASM; DATA ANALYSIS; DNA DAMAGE; EXCISION REPAIR; FOLLOW UP; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMAN; IMMUNOREACTIVITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PARENCHYMA; LIVER TRANSPLANTATION; NEEDLE BIOPSY; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK ASSESSMENT;

CARCINOMA, HEPATOCELLULAR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 77952555034     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.045     Document Type: Article

References (24)

1. Bosch F.X., Ribes J., Cleries R., et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 (2005) 191
2. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907
3. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339
4. Simonetti R.G., Camma C., Fiorello F., et al. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci 36 (1991) 962
5. Kawanishi S., and Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8 (2006) 1047
6. Grisham J.W. Molecular genetic alterations in primary hepatocellular neoplasms: hepatocellular adenoma, hepatocellular carcinoma and hepatoblastoma. In: Coleman W.B., and Tsongalis G.J. (Eds). The Molecular Basis of Human Cancer (2001), Humana Press, Totowa, NJ 269
7. Loguercio C., and Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 34 (2003) 1
8. Poli G., and Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med 22 (1997) 287
9. Jüngst C., Cheng B., Gehrke R., et al. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology 39 (2004) 1663
10. Tell G., Damante G., Caldwell D., et al. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?. Antioxid Redox Signal 7 (2005) 367
11. Xanthoudakis S., and Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11 (1992) 653
12. Kelley MR, Moore DH, Cheng L, et al: Altered expression of the multifunctional DNA base excision repair and redox enzyme APE/Ref-1 in ovarian and prostate cancers. In: Proceedings of the AACR Special Conference on DNA Repair Defects, San Diego, Calif, 2000
13. Russo D., Arturi F., Bulotta S., et al. ApeI/Ref-I expression and cellular localization in human thyroid carcinoma cell lines. J Endocrinol Invest 24 (2001) RC10
14. Puglisi F., Barbone F., Tell G., et al. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas. Oncol Rep 9 (2002) 11
15. Edmondson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7 (1954) 462
16. Pines A., Perrone L., Bivi N., et al. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33 (2005) 4379
17. Forner A., Heissheimer A.J., Isabel Real M., et al. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol 60 (2006) 89
18. Belghiti J. Transplantation for liver tumors. Semin Oncol 32 6 Suppl 8 (2005) 29
19. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181
20. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
21. Decaens T., Roudot-Thoraval F., Hadni-Bresson S., et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 12 (2006) 1761
22. Duffy J.P., Vardanian A., Benjamin E., et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246 (2007) 502
23. Masatoshi K., Hobyung C., and Yukio O. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 28 (1998) 751
24. Di Maso V., Avellini C., Crocè L.S., et al. Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med 13 (2007) 89